Evidence map›Paper›PMID 38684797›Full record

ArticleScientific reports2024

Synthesis, molecular docking studies and biological evaluation of N-(4-oxo-2-(trifluoromethyl)-4H-chromen-7-yl) benzamides as potential antioxidant, and anticancer agents.

Sumalatha Jorepalli, Sreedevi Adikay, Radha Rani Chinthaparthi, Chandra Sekhar Reddy Gangireddy, Janardhan Reddy Koduru, Rama Rao Karri

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. ACS omega · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sumalatha JorepalliDepartment of Pharmaceutical Chemistry, Sri Padmavati Mahila Visva Vidyalayam, Tirupati, 517 502, India.
Sreedevi AdikayDepartment of Pharmaceutical Chemistry, Sri Padmavati Mahila Visva Vidyalayam, Tirupati, 517 502, India. sreedevi@spmvv.ac.in.
Radha Rani ChinthaparthiDepartment of Chemistry, Sri Venkateswara College of Engineering, Tirupati, 517 507, India.
Chandra Sekhar Reddy GangireddyDepartment of Chemistry, Sri Venkateswara College of Engineering, Tirupati, 517 507, India.
Janardhan Reddy KoduruDepartment of Environmental Engineering, Kwangwoon University, Seoul, 01897, Republic of Korea. reddyjchem@gmail.com.
Rama Rao KarriPetroleum and Chemical Engineering, Faculty of Engineering, Universiti Teknologi Brunei, Bandar Seri Begawan, BE1410, Brunei Darussalam. kramarao.iitd@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of novel chromone derivatives of (N-(4-oxo-2-(trifluoromethyl)-4H-chromen-6-yl) benzamides) were synthesized by treating 7-amino-2-(trifluoromethyl)-4H-chromen-4-one with K

Indexed as

Antineoplastic AgentsAntioxidantsBenzamidesMolecular Docking SimulationA549 CellsCell Line, TumorChromonesHumansMCF-7 CellsStructure-Activity RelationshipAntineoplastic AgentsAntioxidantsBenzamidesChromonesAntioxidant activityChromonesCytotoxic activityMolecular docking study

Identifiers

PMID38684797
PMCPMC11058781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.